Literature DB >> 4041046

Acute and chronic behavioral interactions between phencyclidine (PCP) and amphetamine: evidence for a dopaminergic role in some PCP-induced behaviors.

B D Greenberg, D S Segal.   

Abstract

Amphetamine and phencyclidine (PCP) are both proposed to exert effects on unconditioned behavior through dopaminergic mechanisms. However, a relatively complete characterization of their effects in rats reveals markedly different response profiles. Furthermore, whereas acute co-administration of amphetamine and PCP resulted in an increase in one component of stereotypy, repetitive head movements, two measures of locomotor activation, i.e., ambulation and nonfocused sniffing, were unchanged, and rearings were reduced. In addition, the response alterations which occur with repeated administration of these drugs did not display cross-sensitization. Thus, although repeated daily injections of amphetamine, which produced progressive locomotor augmentation, sensitized animals to the locomotor-stimulating effects of PCP, repeated PCP treatment, which also resulted in locomotor augmentation, decreased the locomotor response to a challenge injection of amphetamine. These findings suggest significant differences in the mechanisms underlying the effects of acute and repeated administration of PCP and amphetamine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4041046     DOI: 10.1016/0091-3057(85)90137-6

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  13 in total

1.  Upper body 3-dimensional kinematics during gait in psychotic patients: a pilot-study.

Authors:  A Stensdotter; N Pedersen; A Wanvik; F Öhberg; J C Fløvig; E A Fors
Journal:  Exp Brain Res       Date:  2012-07-22       Impact factor: 1.972

2.  Cocaine during adolescence enhances dopamine in response to a natural reinforcer.

Authors:  Briony J Catlow; Cheryl L Kirstein
Journal:  Neurotoxicol Teratol       Date:  2006-11-24       Impact factor: 3.763

3.  Evidence for multiple opiate receptor involvement in different phencyclidine-induced unconditioned behaviors in rats.

Authors:  B D Greenberg; D S Segal
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine.

Authors:  Hyun-Sang Cho; Deepak C D'Souza; Ralitza Gueorguieva; Edward B Perry; Steven Madonick; Laurence P Karper; Anissa Abi-Dargham; Aysenil Belger; Walid Abi-Saab; Deborah Lipschitz; Alexandre Bennet; John P Seibyl; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

5.  Blockade of phencyclidine-induced effects by a nitric oxide donor.

Authors:  M Bujas-Bobanovic; D C Bird; H A Robertson; S M Dursun
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

6.  Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition.

Authors:  Catherine C Tenn; Shitij Kapur; Paul J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2005-04-26       Impact factor: 4.530

7.  Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats.

Authors:  Alice Egerton; Lee Reid; Sandie McGregor; Susan M Cochran; Brian J Morris; Judith A Pratt
Journal:  Psychopharmacology (Berl)       Date:  2008-04-23       Impact factor: 4.530

8.  Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.

Authors:  B Adams; B Moghaddam
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

Review 9.  Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake.

Authors:  Nicole M Avena; Pedro Rada; Bartley G Hoebel
Journal:  Neurosci Biobehav Rev       Date:  2007-05-18       Impact factor: 8.989

10.  Drug-induced circling preference in rats. Correlation with monoamine levels.

Authors:  S F Ali; K J Kordsmeier; B Gough
Journal:  Mol Neurobiol       Date:  1995 Aug-Dec       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.